会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 53. 发明申请
    • Vehicle Integrated Jack Device
    • 车载集成插孔设备
    • US20160264106A1
    • 2016-09-15
    • US14656310
    • 2015-03-12
    • Alain Pierre
    • Alain Pierre
    • B60S9/04
    • B60S9/12
    • A vehicle integrated jack device provides independent extension of separate jack arms controlled from an interior of a vehicle. The assembly includes a vehicle having a frame and a plurality of wheels coupled to the frame. Each of a plurality of jack arms is coupled to and extendable from the frame of the vehicle. Each of the jack arms is positioned proximate an associated one of the wheels. A control unit is positioned in an interior of the vehicle. Each of the jack arms is operationally coupled to the control unit such that each jack arm is independently extendable by operation of the control unit.
    • 车辆集成千斤顶装置提供从车辆内部控制的单独的千斤顶臂的独立延伸。 组件包括具有框架和耦合到框架的多个轮子的车辆。 多个千斤顶臂中的每一个联接到车辆的框架并且可从车辆的框架延伸。 每个千斤顶臂都位于相关的一个轮子附近。 控制单元位于车辆的内部。 每个千斤顶臂可操作地耦合到控制单元,使得每个千斤顶臂可以通过控制单元的操作独立地延伸。
    • 57. 发明授权
    • Benzo[b]pyrano[3,2-h]acridin-7-one compounds
    • 苯并[b]吡喃并[3,2-h]吖啶-7-酮化合物
    • US06642248B2
    • 2003-11-04
    • US10205566
    • 2002-07-25
    • Michel KochFrançois TillequinSylvie MichelElisabeth SeguinAbdelhakim El OmriJohn HickmanAlain PierreBruno PfeifferPierre Renard
    • Michel KochFrançois TillequinSylvie MichelElisabeth SeguinAbdelhakim El OmriJohn HickmanAlain PierreBruno PfeifferPierre Renard
    • A61K314741
    • C07D491/04
    • A compound selected from those of formula (I): wherein: X and Y represent group selected from hydrogen, halogen, mercapto, cyano, nitro, alkyl, trihaloalkyl, trihaloalkylcarbonylamino, —ORa, —NRaRb, —NRa—C(O)—T1, —O—C(O)—T1, —O—T2-NRaRb, —O—T2-ORa, —NRa—T2-NRaRb, —NRa—T2-ORa and —NRa—T2-CO2Ra wherein Ra, Rb, T1, T2 are as defined in the description, R1 represents hydrogen or alkyl, R2 represents a group selected from hydrogen, —ORa, —NRaRb, —NRa—C(O)—T1, —O—C(O)—T1, —O—T2-NRaRb, —O—T2-ORa, —NRa—T2-NRaRb, —NRa—T2-ORa and —NRa—T2-CO2Ra wherein Ra, Rb, T1 and T2 are as defined hereinbefore, R3 and R4 represent hydrogen or alkyl, W represents a group of formula —CH(R5)—CH(R6)—, —CH═C(R7)—, —C(R7)═CH— or —C(O)—CH(R8)— wherein R5, R6, R7 and R8 are as defined in the description, their isomers and N-oxides, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful in the treatment of cancer.
    • 选自式(I)的化合物:其中:X和Y表示选自氢,卤素,巯基,氰基,硝基,烷基,三卤代烷基,三卤代烷基羰基氨基,-OR a,-NR a R b,-NR a -C(O) - T1,-OC(O)-T1,-O-T2-NRaRb,-O-T2-ORa,-NRa-T2-NRaRb,-NRa-T2-ORa和-NRa-T2-CO2Ra,其中Ra,Rb,T1 ,T 2如说明书中所定义,R 1表示氢或烷基,R 2表示选自氢,-OR a,-NR a R b,-NR a -C(O)-T1,-OC(O)-T1,-O- R2-NRaRb,-O-T2-ORa,-NRa-T2-NRaRb,-NRa-T2-ORa和-NRa-T2-CO2Ra,其中Ra,Rb,T1和T2如上所定义,R3和R4代表氢或 烷基,W表示式-CH(R 5)-CH(R 6) - , - CH = C(R 7) - , - C(R 7)= CH-或-C(O)-CH(R 8) R5,R6,R7和R8如说明书中所定义,它们的异构体和N-氧化物及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物,可用于治疗癌症。
    • 58. 发明授权
    • Cycloheptene compounds
    • 环庚烯化合物
    • US06638962B2
    • 2003-10-28
    • US10050666
    • 2002-01-16
    • Patrick CasaraThierry Le DiguarherGilbert DoreyJohn HickmanAlain PierreGordon TuckerNicolas Guilbaud
    • Patrick CasaraThierry Le DiguarherGilbert DoreyJohn HickmanAlain PierreGordon TuckerNicolas Guilbaud
    • A61K314174
    • C07D233/64A61K31/4164C07D213/38C07D401/06
    • Compound of formula (I): wherein: X represents a bond or alkylene, CO, S(O)n, —S(O)n—A1—, —CO—A1—, —A—S(O)n—A′1— or —A1—CO—A′1—, Y represents aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted, R1, R2, R3 and R4 each independently of the others represent hydrogen or aryl, heteroaryl, cycloalkyl or heterocycloalkyl, each unsubstituted or substituted, or R1, R2, R3 and R4, taken in pairs, together form a bond, or form a fused benzene ring or a fused aromatic or partially unsaturated heterocycle, T represents —CH(R5)—, —N(R5)— or —N(R5)CO—, V represents hydrogen or unsubstituted or substituted aryl or heteroaryl, A2 represents [C(R6)(R′6)]p, R7 and R8 are as defined in the description, their isomers and addition salts thereof with a pharmaceutically acceptable acid or base and medicinal products containing the same are useful as farnesyl transferase inhibitors.
    • 式(I)的化合物:其中:X表示键或亚烷基,CO,S(O)n,-S(O)n -A1,-CO-A1-,-AS(O)n-A'1 - 或-A1-CO-A'1-,Y表示芳基,杂芳基,环烷基或杂环烷基,每个未取代或取代的,R 1,R 2,R 3和R 4各自独立地表示氢或芳基,杂芳基,环烷基或杂环烷基, 每个未取代或取代的或R 1,R 2,R 3和R 4成对取代,一起形成键,或形成稠合苯环或稠合芳族或部分不饱和杂环,T表示-CH(R 5) - , - N( R5) - 或-N(R5)CO-,V表示氢或未取代或取代的芳基或杂芳基,A2表示[C(R6)(R'6)] p,R7和R8如说明书中所定义, 并且其与药学上可接受的酸或碱的加成盐和含有它们的药物可用作法呢基转移酶抑制剂。